{"symbol":"SYK","provider":"yahoo-finance","fetchedAt":"2025-12-26T10:11:00.142Z","asOfDate":"2025-12-26","articles":[{"id":"97bd51f2-3949-33f4-a12b-1f41ad8be31e","title":"Is Fidelity Medical Equipment the Ultimate \"Forever Fund\" for Health Care Investors?","url":"https://finance.yahoo.com/m/97bd51f2-3949-33f4-a12b-1f41ad8be31e/is-fidelity-medical-equipment.html","publisher":"Motley Fool","publishedAt":"2025-12-24T13:05:00.000Z","relatedTickers":["XLV"],"mainIdea":"Is Fidelity Medical Equipment the Ultimate \"Forever Fund\" for Health Care Investors?","summary":"Motley Fool: Is Fidelity Medical Equipment the Ultimate \"Forever Fund\" for Health Care Investors?. This basket of 64 medical device stocks could raise its dividend for decades. Related tickers mentioned: XLV."},{"id":"febafd74-97da-3fc1-9a7e-58b33c94a6bf","title":"Intuitive Surgical vs. Stryker: Which MedTech Stock Has More Upside?","url":"https://finance.yahoo.com/news/intuitive-surgical-vs-stryker-medtech-120200684.html","publisher":"Zacks","publishedAt":"2025-12-24T12:02:00.000Z","relatedTickers":["ISRG"],"mainIdea":"Intuitive Surgical vs. Stryker: Which MedTech Stock Has More Upside?","summary":"Zacks: Intuitive Surgical vs. Stryker: Which MedTech Stock Has More Upside?. Intuitive Surgical's robotics-first model, recurring revenue base, and margin leverage differentiate it from Stryker in terms of upside potential today. Related tickers mentioned: ISRG."},{"id":"e6924ba4-51dd-303c-89b3-da4b3b2452ca","title":"Citi Cuts Stryker (SYK) PT, Maintains Buy Amid Leadership Changes","url":"https://finance.yahoo.com/news/citi-cuts-stryker-syk-pt-145323613.html","publisher":"Insider Monkey","publishedAt":"2025-12-22T14:53:23.000Z","relatedTickers":[],"mainIdea":"Citi Cuts Stryker (SYK) PT, Maintains Buy Amid Leadership Changes","summary":"Insider Monkey: Citi Cuts Stryker (SYK) PT, Maintains Buy Amid Leadership Changes. Stryker Corporation (NYSE:SYK) is one of the best healthcare AI stocks to buy now. On December 11, Citi cut the price target on Stryker Corporation (NYSE:SYK) from $455 to $420, while maintaining a Buy rating on the shares. This adjustment, the firm said, is part of a sector-wide adjustment as it formulates its 2026 outlook. [â€¦]"}]}
